Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment:
Arjun P Athreya1, Ravishankar Iyer2, Liewei Wang1
1Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
No abstract available in PubMed .
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Factors Affecting Drug Response: Overview
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Measurement of Bioavailability: Pharmacodynamic Methods
Drug Therapy
Antianxiety Medications